(주)팬젠

{
  "address": "경기도 수원시",
  "ceo_name": "윤재승",
  "certificate": [
    {
      "cert_number": "20100102645",
      "changes": "",
      "disclosure_date": "2010-03-25",
      "first_cert_date": "2010-03-25",
      "no": "1",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2010-03-25 ~ 2012-03-24"
    },
    {
      "cert_number": "20120300057",
      "changes": "",
      "disclosure_date": "2012-02-29",
      "first_cert_date": "2010-03-25",
      "no": "2",
      "type": "벤처투자유형",
      "valid_period": "2012-03-25 ~ 2014-03-24"
    },
    {
      "cert_number": "20140300103",
      "changes": "",
      "disclosure_date": "2014-03-13",
      "first_cert_date": "2010-03-25",
      "no": "3",
      "type": "벤처투자유형",
      "valid_period": "2014-03-25 ~ 2016-03-24"
    },
    {
      "cert_number": "20160300045",
      "changes": "",
      "disclosure_date": "2016-02-11",
      "first_cert_date": "2010-03-25",
      "no": "4",
      "type": "벤처투자유형",
      "valid_period": "2016-03-25 ~ 2018-03-24"
    },
    {
      "cert_number": "20180300124",
      "changes": "",
      "disclosure_date": "2018-02-22",
      "first_cert_date": "2010-03-25",
      "no": "5",
      "type": "벤처투자유형",
      "valid_period": "2018-03-25 ~ 2020-03-24"
    },
    {
      "cert_number": "20200300176",
      "changes": "",
      "disclosure_date": "2020-02-27",
      "first_cert_date": "2010-03-25",
      "no": "6",
      "type": "벤처투자유형",
      "valid_period": "2020-03-25 ~ 2022-03-24"
    },
    {
      "cert_number": "20220223010013",
      "changes": "",
      "disclosure_date": "2022-02-23",
      "first_cert_date": "2010-03-25",
      "no": "7",
      "type": "벤처투자유형",
      "valid_period": "2022-03-25 ~ 2025-03-24"
    },
    {
      "cert_number": "20250304020012",
      "changes": "",
      "disclosure_date": "2025-03-04",
      "first_cert_date": "2010-03-25",
      "no": "8",
      "type": "연구개발유형",
      "valid_period": "2025-03-25 ~ 2028-03-24"
    }
  ],
  "company_name": "주식회사 팬젠",
  "corp_no": "131111-*******",
  "financials": {
    "2022": {
      "capital_stock": 5338815000,
      "cost_of_sales": 5840695000,
      "current_assets": 8576383000,
      "current_liabilities": 1129529000,
      "gross_profit": 659963000,
      "net_income": -4435144000,
      "net_income_bs": -4493832000,
      "non_current_assets": 12097293000,
      "non_current_liabilities": 2324674000,
      "non_operating_expenses": 246138000,
      "non_operating_income": 401623000,
      "operating_profit": -4590629000,
      "revenue": 6500658000,
      "sga_expenses": 5250592000,
      "total_assets": 20673675000,
      "total_equity": 17219473000,
      "total_liabilities": 3454203000
    },
    "2023": {
      "capital_stock": 5338815000,
      "cost_of_sales": 6328831000,
      "current_assets": 9842644000,
      "current_liabilities": 5710648000,
      "gross_profit": 986294000,
      "net_income": -4441406000,
      "net_income_bs": -4488831000,
      "non_current_assets": 10898511000,
      "non_current_liabilities": 2464530000,
      "non_operating_expenses": 416637000,
      "non_operating_income": 200728000,
      "operating_profit": -4225497000,
      "revenue": 7315125000,
      "sga_expenses": 5211791000,
      "total_assets": 20741156000,
      "total_equity": 12565978000,
      "total_liabilities": 8175178000
    }
  },
  "industry": "생물 의약품 제조업",
  "investment": [
    {
      "amount": "10,000,000,000",
      "changes": "10,000,000,000",
      "date": "2018-02-21"
    },
    {
      "amount": "8,000,000,000",
      "changes": "8,000,000,000",
      "date": "2018-02-21"
    },
    {
      "amount": "2,000,000,000",
      "changes": "2,000,000,000",
      "date": "2018-02-21"
    }
  ],
  "main_products": "EPO 의약품 생산,Cell Line,CMO",
  "phone": "031-733-****",
  "years": [
    2023,
    2022
  ]
}